Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Efficacy of doxycycline as add-on to interferon beta-1a in treatment of multiple sclerosis.
Investigation of immune and CNS-mediated effects of fingolimod in the focal delayed-type hypersensitivity multiple sclerosis model.
Mast cells in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis.
Advanced MRI unravels the nature of tissue alterations in early multiple sclerosis.
Prolactin: A versatile regulator of inflammation and autoimmune pathology.
Role of thalamic diffusion for disease differentiation between multiple sclerosis and ischemic cerebral small vessel disease.
[Neuropathology of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy].
Risk for nevus transformation and melanoma proliferation and invasion during natalizumab treatment: four years of dermoscopic follow-up with immunohistological studies and proliferation and invasion assays.
Positive or negative involvement of heat shock proteins in multiple sclerosis pathogenesis: an overview.
Novel Targets in Multiple Sclerosis: to Oxidative Stress and Beyond.
Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome.
Vitamin D in multiple sclerosis patients: Not the same risk for everybody.
Reassessment of Lhermitte's sign in multiple sclerosis.
Biomarkers of Inflammation and Axonal Degeneration/Damage in Patients with Newly Diagnosed Multiple Sclerosis: Contributions of the Soluble CD163 CSF/Serum Ratio to a Biomarker Panel.
Immune Tolerance Induction against Experimental Autoimmune Encephalomyelitis (EAE) Using A New PLP-B7AP Conjugate that Simultaneously Targets B7/CD28 Costimulatory Signal and TCR/MHC-II Signal.
The immune response in the CNS in Theiler's virus induced demyelinating disease switches from an early adaptive response to a chronic innate-like response.
Drug-induced Fanconi syndrome associated with fumaric acid esters treatment for psoriasis: a case series.
A longitudinal study on fatigue, depression, and their relation to neurocognition in multiple sclerosis.
Interferon beta-associated recurrence of painful trigeminal neuropathy attributed to a multiple sclerosis plaque.
Nitric oxide-induced neuronal to glial lineage fate-change depends on NRSF/REST function in neural progenitor cells.
Anti-aquaporin-4 antibody-positive dorsal midbrain syndrome.
The effect of the physiological rest position of the mandible on cerebral blood flow and physical balance: an observational study.
The role of antiproliferative gene Tob1 in the immune system.
Impact of oral health in patients with multiple sclerosis and epilepsy: A survey in a neurology clinic.
Toward the identification of neuroprotective agents: g-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist.
Pages
« first
‹ previous
…
462
463
464
465
466
467
468
469
470
…
next ›
last »